These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 7691316

  • 21. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S, Kimura T, Sakabe H, Ohmizono Y, Kato T, Miyazaki H, Yamagishi H, Sonoda Y.
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [Abstract] [Full Text] [Related]

  • 22. Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33-or low cord blood cells on cytokine-stimulated erythroid colony formation.
    Lu L, Ge Y, Li ZH, Xiao M, Broxmeyer HE.
    Exp Hematol; 1996 Feb; 24(2):347-51. PubMed ID: 8641364
    [Abstract] [Full Text] [Related]

  • 23. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
    Visani G, Tosi P, Finelli C, Gamberi B, Zauli G, Cenacchi A, Fogli M, Colombini R, Tura S.
    Haematologica; 1992 Feb; 77(2):142-5. PubMed ID: 1383105
    [Abstract] [Full Text] [Related]

  • 24. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N, Koike K, Ito S, Okumura N, Kamijo T, Shiohara M, Amano Y, Tsuji K, Nakahata T, Oda M.
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [Abstract] [Full Text] [Related]

  • 25. The cellular basis for enhancement interactions between stem cell factor and the colony stimulating factors.
    Metcalf D.
    Stem Cells; 1993 Jul; 11 Suppl 2():1-11. PubMed ID: 7691313
    [Abstract] [Full Text] [Related]

  • 26. Constitutive and induced expression of hematopoietic growth factor genes by fibroblasts from children with Fanconi anemia.
    Bagby GC, Segal GM, Auerbach AD, Onega T, Keeble W, Heinrich MC.
    Exp Hematol; 1993 Oct; 21(11):1419-26. PubMed ID: 7691632
    [Abstract] [Full Text] [Related]

  • 27. Synergy among erythropoietin, interleukin 3, stem cell factor (c-kit ligand) and interferon-gamma on early human hematopoiesis.
    Kawano Y, Takaue Y, Hirao A, Sato J, Abe T, Suzue T, Saito S, Okamoto Y, Kuroda Y.
    Stem Cells; 1994 Sep; 12(5):514-20. PubMed ID: 7528591
    [Abstract] [Full Text] [Related]

  • 28. Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth.
    Barak Y, Hahn T, Pecht M, Karov Y, Berrebi A, Zaizov R, Stark B, Buchner V, Burstein Y, Trainin N.
    Exp Hematol; 1992 Feb; 20(2):173-7. PubMed ID: 1544385
    [Abstract] [Full Text] [Related]

  • 29. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P.
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [Abstract] [Full Text] [Related]

  • 30. c-kit ligand augments granulocyte-macrophage colony growth from patients with 5q- syndrome.
    Rosenfeld CS, Nemunaitis J, Sherer CR, Zeigler ZR, Shadduck RK.
    Stem Cells; 1993 Nov; 11(6):562-7. PubMed ID: 7509225
    [Abstract] [Full Text] [Related]

  • 31. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ.
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [Abstract] [Full Text] [Related]

  • 32. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A, Shibata A.
    Hematol Pathol; 1992 Feb; 6(3):143-53. PubMed ID: 1429342
    [Abstract] [Full Text] [Related]

  • 33. Effect of c-kit ligand (stem cell factor) in combination with interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3, on eosinophil lineage.
    Kobayashi H.
    Int J Hematol; 1993 Aug; 58(1-2):21-6. PubMed ID: 7693027
    [Abstract] [Full Text] [Related]

  • 34. Maintenance and expansion of erythropoiesis in human long-term bone marrow cultures in presence of erythropoietin plus stem cell factor and interleukin-3 or interleukin-11.
    Hassan HT, Biermann B, Zander AR.
    Eur Cytokine Netw; 1996 Aug; 7(2):129-36. PubMed ID: 8688490
    [Abstract] [Full Text] [Related]

  • 35. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 36. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 Dec; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 37. Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro.
    Migliaccio G, Migliaccio AR, Druzin ML, Giardina PJ, Zsebo KM, Adamson JW.
    J Cell Physiol; 1991 Sep; 148(3):503-9. PubMed ID: 1717499
    [Abstract] [Full Text] [Related]

  • 38. In polycythemia vera human interleukin 3 and granulocyte-macrophage colony-stimulating factor enhance erythroid colony growth in the absence of erythropoietin.
    de Wolf JT, Beentjes JA, Esselink MT, Smit JW, Halie RM, Clark SC, Vellenga E.
    Exp Hematol; 1989 Oct; 17(9):981-3. PubMed ID: 2673832
    [Abstract] [Full Text] [Related]

  • 39. Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.
    de Haan G, Loeffler M, Nijhof W.
    Exp Hematol; 1992 Jun; 20(5):600-4. PubMed ID: 1375161
    [Abstract] [Full Text] [Related]

  • 40. Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.
    Herrmann F, Mertelsmann R, Lindemann A, Ottmann OG, Seipelt G, Oster W, Hoelzer D, Ganser A.
    Biotechnol Ther; 1991 Jun; 2(3-4):299-311. PubMed ID: 1845132
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.